Skip to content
value.today

Vascular Dynamics, Inc.

Total raised
$51 M
3 rounds on record
Latest round
$33 M
Jun 2020
First round on record
Feb 2012
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vascular Dynamics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2020$33 MNo. 3$10 to $50 million

Vascular Dynamics, Inc.: Raise no. 3, Jun 2020

Investors in this round

23 investors had bought by the notice of Jun 25, 2020: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $38 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edmund Roschak · Executive Officer, Director
  • J. Casey McGlynn · Executive Officer
  • Gary Burbach · Director
  • Ilan Neugarten · Director
  • Michael Henson · Director
  • Thomas Thaler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Edmund Roschak, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 25, 2020. Read the notice at the SEC.

equitySEC
Oct 2014$10 MNo. 2$2 to $10 million

Vascular Dynamics, Inc.: Raise no. 2, Oct 2014

Investors in this round

20 investors had bought by the notice of Nov 5, 2014: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $23 M offered; $13 M still to sell
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edward F Ruppel, Jr. · Executive Officer
  • Robert Stern · Executive Officer, Director
  • Benjamin Tsai · Director
  • Efraim Cohen Arazi · Director
  • Michael Henson · Director
  • Thomas Thaler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Stern, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 5, 2014. Read the notice at the SEC.

equity, optionsSEC
Feb 2012$9 MNo. 1$2 to $10 million

Vascular Dynamics, Inc.: Raise no. 1, Feb 2012

Investors in this round

16 investors had bought by the notice of Mar 5, 2012: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $15 M offered; $7 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Stern · Executive Officer, Director
  • Benjamin Tsai · Director
  • Bryan Kim · Director
  • Efraim Cohen Arazi · Director
  • Yossi Gross · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Stern, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 5, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vascular Dynamics, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2020).

    SEC Form D · Jun 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2020

That is all the official record says: Vascular Dynamics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vascular Dynamics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 23 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vascular Dynamics, Inc.
NameRoleNamed in
Edmund RoschakExecutive officerJun 2020
J. Casey McGlynnExecutive officerJun 2020
Edward F Ruppel, Jr.Executive officerNov 2014
Robert SternExecutive officerNov 2014
Edmund RoschakDirectorJun 2020
Gary BurbachDirectorJun 2020
Ilan NeugartenDirectorJun 2020
Michael HensonDirectorJun 2020
Thomas ThalerDirectorJun 2020
Benjamin TsaiDirectorNov 2014
Efraim Cohen AraziDirectorNov 2014
Robert SternDirectorNov 2014
Bryan KimDirectorMar 2012
Yossi GrossDirectorMar 2012